ML11229A081: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
(3 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
| number = ML11229A081 | | number = ML11229A081 | ||
| issue date = 10/29/2009 | | issue date = 10/29/2009 | ||
| title = | | title = Lr Hearing - NIA-089 | ||
| author name = | | author name = | ||
| author affiliation = Sandia National Labs (SNL) | | author affiliation = Sandia National Labs (SNL) | ||
Line 16: | Line 16: | ||
=Text= | =Text= | ||
{{#Wiki_filter:* File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM | {{#Wiki_filter:NIA-089 | ||
* DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP' | * File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM | ||
* DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP' | |||
* EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES' | * EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES' | ||
* ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE. | |||
* ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE. | * IPLUME - dispersion code option MIIPLUME001 2 | ||
* NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7 | |||
* IPLUME - dispersion code option MIIPLUME001 2 | * IPRINT - amount of output desired MIIPRINT001 0 | ||
* NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7 | |||
* IPRINT - amount of output desired MIIPRINT001 0 | |||
* POPFLG - is population uniform or defined by Site Data File. | * POPFLG - is population uniform or defined by Site Data File. | ||
PDPOPFLG001 FILE | PDPOPFLG001 FILE | ||
* ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE. | |||
* ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE. MIORGDEF002 | MIORGDEF002 'A-RED MARR' .TRUE. | ||
'A-RED MARR' .TRUE. MIORGDEF003 A-LUNGS .TRUE. | MIORGDEF003 A-LUNGS .TRUE. | ||
MIORGDEF004 A-THYROIDH .TRUE. | MIORGDEF004 A-THYROIDH .TRUE. | ||
MIORGDEF005 A-STOMACH .TRUE. | MIORGDEF005 A-STOMACH .TRUE. | ||
MIORGDEF006 | MIORGDEF006 'A-LOWER LI' .FALSE. | ||
'A-LOWER LI' .FALSE. MIORGDEF007 L-EDEWBODY .TRUE. | MIORGDEF007 L-EDEWBODY .TRUE. | ||
MIORGDEF008 | MIORGDEF008 'L-RED MARR' .TRUE. | ||
'L-RED MARR' .TRUE. MIORGDEF009 | MIORGDEF009 'L-BONE SUR' .TRUE. | ||
'L-BONE SUR' .TRUE. | MIORGDEF010 L-BREAST .TRUE. | ||
MIORGDEF010 L-BREAST .TRUE. MIORGDEF011 L-LUNGS .TRUE. | MIORGDEF011 L-LUNGS .TRUE. | ||
MIORGDEF012 L-THYROID .TRUE. | MIORGDEF012 L-THYROID .TRUE. | ||
MIORGDEF013 | MIORGDEF013 'L-LOWER LI' .TRUE. | ||
'L-LOWER LI' .TRUE. MIORGDEF014 | MIORGDEF014 'L-BLAD WAL' .TRUE. | ||
'L-BLAD WAL' .TRUE. MIORGDEF015 L-LIVER .FALSE. | MIORGDEF015 L-LIVER .FALSE. | ||
MIORGDEF016 L-THYROIDH .TRUE. | MIORGDEF016 L-THYROIDH .TRUE. | ||
* RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE. | |||
* RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE. | * OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE. | ||
* OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE. | NIA-089 | ||
* CSFACT - Cloudshine shielding factor SECSFACT001 | * CSFACT - Cloudshine shielding factor SECSFACT001 1. | ||
SECSFACT002 0.75 SECSFACT003 0.6 | |||
* PROTIN - Inhalation protection factor SEPROTIN001 1. | |||
* PROTIN - Inhalation protection factor SEPROTIN001 | SEPROTIN002 0.41 SEPROTIN003 0.33 | ||
* BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4 | |||
* SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC003 0.33 | |||
* BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4 | * GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2 | ||
* SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 | * RESCON - Initial value for emergency-phase resuspension concentration factor. | ||
* GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2 | SERESCON001 1.E-4 | ||
* RESCON - Initial value for emergency-phase resuspension concentration factor. SERESCON001 1.E-4 | |||
* RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life. | * RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life. | ||
SERESHAF001 1.82E5 | SERESHAF001 1.82E5 | ||
* EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE' | |||
* EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE' | * WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE | ||
* WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00 | |||
* WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE | * LASMOV2 (used for no evacuation), always 0 EZLASMOV001 0 | ||
* WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00 | * ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800. | ||
* LASMOV2 | * CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY | ||
* ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800. | NIA-089 | ||
* CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY | * TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200. | ||
* TIMNRM - Normal Relocation Time (Seconds from Plume Arrival) | |||
* TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200. | SRTIMNRM001 86400. | ||
* TIMNRM - Normal Relocation Time (Seconds from Plume Arrival) SRTIMNRM001 86400. | |||
* DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts) | * DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts) | ||
SRDOSHOT001 0.5 | SRDOSHOT001 0.5 | ||
* DOSNRM - Normal Relocation Dose Threshold (Sieverts) | * DOSNRM - Normal Relocation Dose Threshold (Sieverts) | ||
SRDOSNRM001 0.25 | SRDOSNRM001 0.25 | ||
* NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2 | |||
* NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2 | |||
* ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts) | * ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts) | ||
EFATAGRP001 | EFATAGRP001 'A-RED MARR' 3.8 5.0 1.5 EFATAGRP002 A-LUNGS 10.0 7.0 5.0 | ||
'A-RED MARR' 3.8 5.0 1.5 EFATAGRP002 A-LUNGS 10.0 7.0 5.0 | * NUMEIN - Number of Early Injury Effects EINUMEIN001 7 | ||
* ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor. | |||
* NUMEIN - Number of Early Injury Effects EINUMEIN001 7 | EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH 1. .5 2. 3. | ||
EINJUGRP002 DIARRHEA A-STOMACH 1. 1. 3. 2.5 EINJUGRP003 PNEUMONITIS A-LUNGS 1. 5. 10. 7. | |||
* ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor. EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH | EINJUGRP004 'SKIN ERYTHEMA' A-SKIN 1. 3. 6. 5. | ||
EINJUGRP005 TRANSEPIDERMAL A-SKIN 1. 10. 20. 5. | |||
EINJUGRP006 THYROIDITIS A-THYROIDH 1. 40. 240. 2. | |||
EINJUGRP007 HYPOTHYROIDISM A-THYROIDH 1. 2. 60. 1.3 | |||
* NUMACA - number of latent cancer effects LCNUMACA001 7 | |||
* ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0 | |||
* DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2 | |||
* ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA 'L-RED MARR' 1.0 1.0 0.0 9.70E-3 0.0 2.0 LCANCERS002 BONE 'L-BONE SUR' 1.0 1.0 0.0 9.00E-4 0.0 2.0 LCANCERS003 BREAST L-BREAST 1.0 1.0 0.0 5.40E-3 1.7E-2 1.0 | |||
* NUMACA - number of latent cancer effects LCNUMACA001 7 | |||
* ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0 | NIA-089 LCANCERS004 LUNG L-LUNGS 1.0 1.0 0.0 1.55E-2 0.0 2.0 LCANCERS005 THYROID L-THYROIDH 1.0 1.0 0.0 7.20E-4 7.2E-3 1.0 LCANCERS006 GI 'L-LOWER LI' 1.0 1.0 0.0 3.36E-2 0.0 2.0 LCANCERS007 OTHER L-EDEWBODY 1.0 1.0 0.0 2.76E-2 0.0 2.0 | ||
* DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2 | * NUM1=0 TYPE1NUMBER 0 | ||
* NUM1 - Number of results of type 1 TYPE1NUMBER 4 | |||
* ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA | * NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL' 1 15 NONE TYPE1OUT002 'CAN FAT/TOTAL' 1 15 NONE TYPE1OUT003 'CAN FAT/TOTAL' 1 11 NONE TYPE1OUT004 'ERL FAT/TOTAL' 1 11 NONE | ||
'L-RED MARR' 1.0 1.0 0.0 9.70E-3 0.0 2.0 LCANCERS002 BONE | * NUM2=0 TYPE2NUMBER 0 | ||
'L-BONE SUR' 1.0 1.0 0.0 9.00E-4 0.0 2.0 LCANCERS003 BREAST L-BREAST 1.0 1.0 0.0 5.40E-3 1.7E-2 1.0 LCANCERS004 LUNG L-LUNGS 1.0 1.0 0.0 1.55E-2 0.0 2.0 LCANCERS005 THYROID L-THYROIDH 1.0 1.0 0.0 7.20E-4 7.2E-3 1.0 LCANCERS006 GI 'L-LOWER LI' 1.0 1.0 0.0 3.36E-2 0.0 2.0 LCANCERS007 OTHER L-EDEWBODY 1.0 1.0 0.0 2.76E-2 0.0 2.0 | * NUM3=0 TYPE3NUMBER 0 | ||
* NUM4=0 TYPE4NUMBER 0 | |||
* NUM1=0 TYPE1NUMBER 0 | * NUM4 - Number of results of type 4 TYPE4NUMBER 3 | ||
* I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1 'ERL FAT/TOTAL' NONE TYPE4OUT002 2 'ERL FAT/TOTAL' NONE TYPE4OUT003 3 'ERL FAT/TOTAL' NONE | |||
* NUM1 - Number of results of type 1 TYPE1NUMBER 4 | * NUM5 =0 TYPE5NUMBER 0 | ||
* NUM5 - Number of results of type 5 TYPE5NUMBER 1 | |||
* NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL' 1 15 NONE TYPE1OUT002 'CAN FAT/TOTAL' 1 15 NONE TYPE1OUT003 'CAN FAT/TOTAL' 1 11 NONE TYPE1OUT004 'ERL FAT/TOTAL' 1 11 NONE | * NAME5, I1DIS5, CCDF5 - Population Dose TYPE5OUT001 L-EDEWBODY 1 15 NONE | ||
* NUM2=0 TYPE2NUMBER 0 | * NUM6 =0 TYPE6NUMBER 0 | ||
* NUM7=0 TYPE7NUMBER 0 | |||
* NUM3=0 TYPE3NUMBER 0 | |||
NIA-089 | |||
* NUM4=0 TYPE4NUMBER 0 | * NUM8=0 TYPE8NUMBER 0 | ||
* NUM4 - Number of results of type 4 TYPE4NUMBER 3 | * NUM8 - Number of results of type 8 TYPE8NUMBER 2 | ||
* I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1 'ERL FAT/TOTAL' NONE TYPE4OUT002 2 'ERL FAT/TOTAL' NONE TYPE4OUT003 3 'ERL FAT/TOTAL' NONE | * NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL' 1 3 NONE TYPE8OUT002 'CAN FAT/TOTAL' 1 11 NONE | ||
* NUMA=0 TYPEANUMBER 0 | |||
* NUM5 =0 TYPE5NUMBER 0 | * NUMB =0 TYPEBNUMBER 0 | ||
* NUM5 - Number of results of type 5 TYPE5NUMBER 1 | * NUMB - Number of results of type B TYPEBNUMBER 20 | ||
* NAME5, I1DIS5, | * NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1 1 NONE TYPEBOUT002 L-EDEWBODY 2 1 NONE TYPEBOUT003 L-EDEWBODY 3 1 NONE TYPEBOUT004 L-EDEWBODY 4 1 NONE TYPEBOUT005 L-EDEWBODY 5 1 NONE TYPEBOUT006 L-EDEWBODY 6 1 NONE TYPEBOUT007 L-EDEWBODY 7 1 NONE TYPEBOUT008 L-EDEWBODY 8 1 NONE TYPEBOUT009 L-EDEWBODY 9 1 NONE TYPEBOUT010 L-EDEWBODY 10 1 NONE TYPEBOUT011 L-EDEWBODY 1 9 NONE TYPEBOUT012 L-EDEWBODY 2 9 NONE TYPEBOUT013 L-EDEWBODY 3 9 NONE TYPEBOUT014 L-EDEWBODY 4 9 NONE TYPEBOUT015 L-EDEWBODY 5 9 NONE TYPEBOUT016 L-EDEWBODY 6 9 NONE TYPEBOUT017 L-EDEWBODY 7 9 NONE TYPEBOUT018 L-EDEWBODY 8 9 NONE TYPEBOUT019 L-EDEWBODY 9 9 NONE TYPEBOUT020 L-EDEWBODY 10 9 NONE | ||
* NUM6 =0 TYPE6NUMBER 0 | * NUMC=0 TYPECNUMBER 0 | ||
* NUM7=0 TYPE7NUMBER 0 | * NUMD = 0 TYPEDNUMBER 0 | ||
* NUM8=0 TYPE8NUMBER 0 | NIA-089 | ||
* DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT | |||
* NUM8 - Number of results of type 8 TYPE8NUMBER 2 | * KIMODL, KI model EZKIMODL001 NOKI | ||
* NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL' 1 3 NONE TYPE8OUT002 'CAN FAT/TOTAL' 1 11 NONE | * EFFACY, KI Ingestion EZEFFACY001 0. | ||
* NUMA=0 TYPEANUMBER 0 | * POPFRAC, KI Ingestion EZPOPFRC001 0. | ||
.}} | |||
* NUMB =0 TYPEBNUMBER 0 | |||
* NUMB - Number of results of type B TYPEBNUMBER 20 | |||
* NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1 1 NONE TYPEBOUT002 L-EDEWBODY 2 1 NONE TYPEBOUT003 L-EDEWBODY 3 1 NONE TYPEBOUT004 L-EDEWBODY 4 1 NONE TYPEBOUT005 L-EDEWBODY 5 1 NONE TYPEBOUT006 L-EDEWBODY 6 1 NONE TYPEBOUT007 L-EDEWBODY 7 1 NONE TYPEBOUT008 L-EDEWBODY 8 1 NONE TYPEBOUT009 L-EDEWBODY 9 1 NONE TYPEBOUT010 L-EDEWBODY 10 1 NONE TYPEBOUT011 L-EDEWBODY 1 9 NONE TYPEBOUT012 L-EDEWBODY 2 9 NONE TYPEBOUT013 L-EDEWBODY 3 9 NONE TYPEBOUT014 L-EDEWBODY 4 9 NONE TYPEBOUT015 L-EDEWBODY 5 9 NONE TYPEBOUT016 L-EDEWBODY 6 9 NONE TYPEBOUT017 L-EDEWBODY 7 9 NONE TYPEBOUT018 L-EDEWBODY 8 9 NONE TYPEBOUT019 L-EDEWBODY 9 9 NONE TYPEBOUT020 L-EDEWBODY 10 9 NONE | |||
* NUMC=0 TYPECNUMBER 0 | |||
* NUMD = 0 TYPEDNUMBER 0 | |||
* DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT | |||
* KIMODL, KI model EZKIMODL001 NOKI | |||
* EFFACY, | |||
* POPFRAC, KI Ingestion EZPOPFRC001 | |||
Latest revision as of 18:02, 10 March 2020
ML11229A081 | |
Person / Time | |
---|---|
Site: | Indian Point |
Issue date: | 10/29/2009 |
From: | Sandia |
To: | Office of Nuclear Reactor Regulation |
References | |
NIA-089 | |
Download: ML11229A081 (6) | |
Text
NIA-089
- File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM
- DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP'
- EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES'
- ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE.
- IPLUME - dispersion code option MIIPLUME001 2
- NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7
- IPRINT - amount of output desired MIIPRINT001 0
- POPFLG - is population uniform or defined by Site Data File.
PDPOPFLG001 FILE
- ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE.
MIORGDEF002 'A-RED MARR' .TRUE.
MIORGDEF003 A-LUNGS .TRUE.
MIORGDEF004 A-THYROIDH .TRUE.
MIORGDEF005 A-STOMACH .TRUE.
MIORGDEF006 'A-LOWER LI' .FALSE.
MIORGDEF007 L-EDEWBODY .TRUE.
MIORGDEF008 'L-RED MARR' .TRUE.
MIORGDEF009 'L-BONE SUR' .TRUE.
MIORGDEF010 L-BREAST .TRUE.
MIORGDEF011 L-LUNGS .TRUE.
MIORGDEF012 L-THYROID .TRUE.
MIORGDEF013 'L-LOWER LI' .TRUE.
MIORGDEF014 'L-BLAD WAL' .TRUE.
MIORGDEF015 L-LIVER .FALSE.
MIORGDEF016 L-THYROIDH .TRUE.
- RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE.
- OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE.
NIA-089
- CSFACT - Cloudshine shielding factor SECSFACT001 1.
SECSFACT002 0.75 SECSFACT003 0.6
- PROTIN - Inhalation protection factor SEPROTIN001 1.
SEPROTIN002 0.41 SEPROTIN003 0.33
- BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4
- SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC003 0.33
- GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2
- RESCON - Initial value for emergency-phase resuspension concentration factor.
SERESCON001 1.E-4
- RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life.
SERESHAF001 1.82E5
- EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE'
- WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE
- WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00
- LASMOV2 (used for no evacuation), always 0 EZLASMOV001 0
- ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800.
- CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY
NIA-089
- TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200.
- TIMNRM - Normal Relocation Time (Seconds from Plume Arrival)
SRTIMNRM001 86400.
- DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts)
SRDOSHOT001 0.5
- DOSNRM - Normal Relocation Dose Threshold (Sieverts)
SRDOSNRM001 0.25
- NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2
- ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts)
EFATAGRP001 'A-RED MARR' 3.8 5.0 1.5 EFATAGRP002 A-LUNGS 10.0 7.0 5.0
- NUMEIN - Number of Early Injury Effects EINUMEIN001 7
- ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor.
EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH 1. .5 2. 3.
EINJUGRP002 DIARRHEA A-STOMACH 1. 1. 3. 2.5 EINJUGRP003 PNEUMONITIS A-LUNGS 1. 5. 10. 7.
EINJUGRP004 'SKIN ERYTHEMA' A-SKIN 1. 3. 6. 5.
EINJUGRP005 TRANSEPIDERMAL A-SKIN 1. 10. 20. 5.
EINJUGRP006 THYROIDITIS A-THYROIDH 1. 40. 240. 2.
EINJUGRP007 HYPOTHYROIDISM A-THYROIDH 1. 2. 60. 1.3
- NUMACA - number of latent cancer effects LCNUMACA001 7
- ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0
- DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2
- ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA 'L-RED MARR' 1.0 1.0 0.0 9.70E-3 0.0 2.0 LCANCERS002 BONE 'L-BONE SUR' 1.0 1.0 0.0 9.00E-4 0.0 2.0 LCANCERS003 BREAST L-BREAST 1.0 1.0 0.0 5.40E-3 1.7E-2 1.0
NIA-089 LCANCERS004 LUNG L-LUNGS 1.0 1.0 0.0 1.55E-2 0.0 2.0 LCANCERS005 THYROID L-THYROIDH 1.0 1.0 0.0 7.20E-4 7.2E-3 1.0 LCANCERS006 GI 'L-LOWER LI' 1.0 1.0 0.0 3.36E-2 0.0 2.0 LCANCERS007 OTHER L-EDEWBODY 1.0 1.0 0.0 2.76E-2 0.0 2.0
- NUM1=0 TYPE1NUMBER 0
- NUM1 - Number of results of type 1 TYPE1NUMBER 4
- NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL' 1 15 NONE TYPE1OUT002 'CAN FAT/TOTAL' 1 15 NONE TYPE1OUT003 'CAN FAT/TOTAL' 1 11 NONE TYPE1OUT004 'ERL FAT/TOTAL' 1 11 NONE
- NUM2=0 TYPE2NUMBER 0
- NUM3=0 TYPE3NUMBER 0
- NUM4=0 TYPE4NUMBER 0
- NUM4 - Number of results of type 4 TYPE4NUMBER 3
- I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1 'ERL FAT/TOTAL' NONE TYPE4OUT002 2 'ERL FAT/TOTAL' NONE TYPE4OUT003 3 'ERL FAT/TOTAL' NONE
- NUM5 =0 TYPE5NUMBER 0
- NUM5 - Number of results of type 5 TYPE5NUMBER 1
- NAME5, I1DIS5, CCDF5 - Population Dose TYPE5OUT001 L-EDEWBODY 1 15 NONE
- NUM6 =0 TYPE6NUMBER 0
- NUM7=0 TYPE7NUMBER 0
NIA-089
- NUM8=0 TYPE8NUMBER 0
- NUM8 - Number of results of type 8 TYPE8NUMBER 2
- NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL' 1 3 NONE TYPE8OUT002 'CAN FAT/TOTAL' 1 11 NONE
- NUMA=0 TYPEANUMBER 0
- NUMB =0 TYPEBNUMBER 0
- NUMB - Number of results of type B TYPEBNUMBER 20
- NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1 1 NONE TYPEBOUT002 L-EDEWBODY 2 1 NONE TYPEBOUT003 L-EDEWBODY 3 1 NONE TYPEBOUT004 L-EDEWBODY 4 1 NONE TYPEBOUT005 L-EDEWBODY 5 1 NONE TYPEBOUT006 L-EDEWBODY 6 1 NONE TYPEBOUT007 L-EDEWBODY 7 1 NONE TYPEBOUT008 L-EDEWBODY 8 1 NONE TYPEBOUT009 L-EDEWBODY 9 1 NONE TYPEBOUT010 L-EDEWBODY 10 1 NONE TYPEBOUT011 L-EDEWBODY 1 9 NONE TYPEBOUT012 L-EDEWBODY 2 9 NONE TYPEBOUT013 L-EDEWBODY 3 9 NONE TYPEBOUT014 L-EDEWBODY 4 9 NONE TYPEBOUT015 L-EDEWBODY 5 9 NONE TYPEBOUT016 L-EDEWBODY 6 9 NONE TYPEBOUT017 L-EDEWBODY 7 9 NONE TYPEBOUT018 L-EDEWBODY 8 9 NONE TYPEBOUT019 L-EDEWBODY 9 9 NONE TYPEBOUT020 L-EDEWBODY 10 9 NONE
- NUMC=0 TYPECNUMBER 0
- NUMD = 0 TYPEDNUMBER 0
NIA-089
- DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT
- KIMODL, KI model EZKIMODL001 NOKI
- EFFACY, KI Ingestion EZEFFACY001 0.
- POPFRAC, KI Ingestion EZPOPFRC001 0.
.